clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Healthcare Informatics
Molecular Diagnostics
Oncology/Therapeutics
Translational Research
Multimedia
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
On Demand Webinars
Upcoming Webinars
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Contact IPM
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Immunotherapies
Cancer-Killing Oncolytic Virus Against Solid Tumors Enters Phase 1 Trial
Liver Cancer
Novel Method May Predict HCC Immunotherapy Response
Biomarkers
Lung Cancer Follow-Up Delays Common After High-Risk Screening Result
Brain Cancer
FAP-Targeting Imaging Tracker Prepares for Phase 1 Brain Cancer Trial
Bladder Cancer
Immunotherapy Reduces Bladder Cancer Recurrence
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Healthcare Informatics
Molecular Diagnostics
Oncology/Therapeutics
Translational Research
Multimedia
All
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
Virtual Event
A Successful CDx Strategy: Discovery through Commercialization
Upcoming Webinars
Automated Liquid Handlers: Optimizing Performance and Standardizing Verification
On Demand Webinars
Can Genomic Surveillance Detect the Next Pandemic before It’s Too Late?
On Demand Webinars
Personalize Oncology through Therapy Biosimulation to Improve Patient Outcomes
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Companies
Oxford Nanopore
Oxford Nanopore
Companies
Sequencing and COVID-19: From Genomic Epidemiology to Host Response
Chris Anderson
-
July 1, 2021
0
Companies
Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms
Kathy Vuksanaj
-
March 25, 2020
0
Companies
New Tools for Studying Genetic Variation in Cancer
Kathy Vuksanaj
-
March 25, 2020
0
eBooks
Clinical Research in a Real-Time Sequencing Age
Kathy Vuksanaj
-
March 20, 2020
0
Companies
From Bench to Clinic—The Potential of New Sequencing Tools
Kathy Vuksanaj
-
February 7, 2020
0
Companies
Going Deeper into Long Reads: Oxford Nanopore Licenses CRISPR-Cas9 IP from Caribou
Julianna LeMieux, Ph.D.
-
September 19, 2019
0
Biomarkers
Oxford Nanopore Opens Factory to Meet Demand for MinION, Other DNA/RNA Sequencers
Alex Philippidis
-
July 9, 2019
0
1
2
Page 1 of 2
Trending
Cancer-Killing Oncolytic Virus Against Solid Tumors Enters Phase 1 Trial
May 18, 2022
Novel Method May Predict HCC Immunotherapy Response
May 18, 2022
FAP-Targeting Imaging Tracker Prepares for Phase 1 Brain Cancer Trial
May 18, 2022
Immunotherapy Reduces Bladder Cancer Recurrence
May 18, 2022